Tsumura & Co.
4540.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$281.19B
Close$
Share Statistics
| Market cap | $281.19 Billion |
|---|---|
| Enterprise Value | $351.46 Billion |
| Dividend Yield | $147.00 (4.19%) |
| Earnings per Share | $376.28 |
| Beta | 0.07 |
| Outstanding Shares | 74,545,980 |
Return
| Return on Equity | 9.34% |
|---|---|
| Return on Assets | 5.07% |
| Return on Invested Capital | 8.42% |
Valuation & Multiples
| P/E Ratio | 9.31 |
|---|---|
| PEG | 19.89 |
| Price to Sales | 1.41 |
| Price to Book Ratio | 0.75 |
| Enterprise Value to Revenue | 1.76 |
| Enterprise Value to EBIT | 8.38 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.42 |
| Debt to Equity | 0.45 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$49.84 B
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$109.75
Average shareholder expectationRevenue Estimate
$54.37 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Tsumura & Co.
4,923 employees
CEO: Terukazu Kato Established in Tokyo, Japan, in 1893, Tsumura & Co. operates worldwide in the pharmaceutical sector. The company's core business involves the creation and international distribution of various medicinal products, with a particular focus ...